個股熱度排行 | 3月18日港股收盤
根據uSMART輿情監測數據,18日港股交易時段,市場關注指數最高的5只股票是長和、阿裏巴巴-SW、中國平安、長實集團、藥明生物。3月18日—港股關注排行TOP5
長和
關注度第一爲長和,該股今日收盤上漲3.82%,報於57.10港元。近5個交易日累計上漲4.67%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
瑞銀降長和目標價5%至67.5港元 料基本面復甦與股票回購推動其資產淨值折價收窄
美銀證券:重申長和“買入”評級 目標價70港元
阿裏巴巴-SW
關注度第二爲阿裏巴巴-SW,該股今日收盤下跌3.58%,報於98.35港元。近5個交易日累計上漲8.31%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
恆指跌1.25% 阿裏巴巴-SW早盤低開逾4%
恆生指數低開1.25%報21232點 阿裏巴巴跌4.75%
中國平安
關注度第三爲中國平安,該股今日收盤上漲4.79%,報於57.95港元。近5個交易日累計上漲5.65%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
交銀維持中國平安買入評級 指全年歸母營運利潤符預期
中國平安:股份回購非常規做法 繼續選取優質風險投資
長實集團
關注度第四爲長實集團,該股今日收盤上漲2.37%,報於51.75港元。近5個交易日累計上漲0.29%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
瑞信降長實集團目標價1.7%至63.9港元 維持“跑贏大市”評級
大摩上調長實集團目標價至60元 評級「增持」
藥明生物
關注度第五爲藥明生物,該股今日收盤下跌5.39%,報於53.55港元。近5個交易日累計上漲0.56%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
大和升藥明生物評級至「買入」 目標價下調至72元
醫藥股集體回調,藥明生物跌近9%,藥明康德跌近8%
此外,監測期內有4只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。
3月18日—港股輿情轉折預警
藥明生物
藥明生物輿情扭轉指數達100,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有:
大和升藥明生物評級至「買入」 目標價下調至72元
醫藥股集體回調,藥明生物跌近9%,藥明康德跌近8%
嗶哩嗶哩-SW
嗶哩嗶哩-SW輿情扭轉指數達97,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有:
科指跌幅收窄至2.7% 百度及ASM逆升逾4% 惟嗶哩嗶哩急吐13%
快訊:港股恆指低開1.25% 恆生科指跌2.84%嗶哩嗶哩跌近11%
福耀玻璃
福耀玻璃輿情扭轉指數達97,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有:
瑞信下調福耀玻璃目標價至27元 評級「跑輸大市」
福耀玻璃績後跌超10% 四季度純利同比下滑37.3% 中金下調目標價超30%
阿裏巴巴-SW
阿裏巴巴-SW輿情扭轉指數達96,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有:
恆指跌1.25% 阿裏巴巴-SW早盤低開逾4%
恆生指數低開1.25%報21232點 阿裏巴巴跌4.75%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.